This trial is active, not recruiting.

Condition dental pulp necrosis
Treatment chlorexidine
Phase phase 2
Sponsor Universidade Federal do Ceara
Start date October 2007
End date November 2008
Trial size 30 participants
Trial identifier NCT00624572, CHX0784


The purpose of this study is to evaluate the action of the chlorexidine as intracanal medicament in the reduction of the levels of bacteria inside root canals of primary molar teeth with pulpal necrosis.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model single group assignment
Masking single blind (subject)
Primary purpose treatment

Eligibility Criteria

Male or female participants from 4 years up to 8 years old.

Inclusion Criteria: - Healthy children of both gender; - Without history of reactions or alergical diseases; - With situated age between 04 and 08 years of age - With normal standard of growth and development - Patients with necessity of radical endodontic treatment (pulpectomy) in, at least, two primary molar teeth in different hemi-arches. Exclusion Criteria: - Patients with history of alergical diseases - Patients with allergy to any type of medicine and/or foods - Patients with comprometimento of its general state of health - Healthy patients with risk to develop bacterial endocardite or patients that their general state of health can be aggravated had the transitory bacteremies, as for example children with congenital cardiac illnesses - Patients who are making use of sistemis antibiotics, or that they have made use of sistemic antibiotic in the period of 3 (three) months before the beginning of the endodontic treatment - With periapical x-ray evidencing less than 2/3 of remaining root of the primary tooth to be treated - Patients whose tooth with endodontic necessity to meet in advanced state of root pathological reabsortion - Patients whose legal responsible or parents to refuse to sign the term of free and clarified assent

Additional Information

Official title Efficacy of 1% Chlorexidine Gel as Intracanal Medicament in Primary Molar Teeth - a Clinical and Microbiological Study
Trial information was received from ClinicalTrials.gov and was last updated in February 2008.
Information provided to ClinicalTrials.gov by Universidade Federal do Ceara.